AI Venture Capital Conflicts ⚡ 2026: Rival Startup Bets
Discover AI venture capital conflicts as firms back venture capital rival startups. Learn AI startup investment signals to protect founder trust and avoid boardroom conflicts.
AI Is Testing Venture Capital's Promise Not to Back Rivals
A venture firm can promise to protect a founder's information. It can't always promise that its next investment won't compete with the founder's company. That gap is getting harder to ignore as AI startups grow quickly, ship adjacent products, and chase overlapping markets.
At TechCrunch Disrupt in October 2026, Benchmark's partners said the venture industry's long-running reluctance to invest in direct rivals is being tested. Their point wasn't that exclusivity no longer matters. It was that companies change direction faster - AI included - and conflicts can show up after the investment is already done.
For founders, this isn't just investor etiquette. A venture firm may have board access, strategic context, and relationships across a portfolio. For investors, trying to avoid every possible overlap can also mean passing on strong companies as markets converge. The real question is how to handle that tension early, before it turns into a surprise. Here's what Benchmark's comments suggest - and what founders and investors can do when the line between "adjacent" and "competing" starts to blur.
Why the no-rivals norm is under pressure
Venture capital has often looked more like a partnership than passive financing. Early-stage investors may join a board, help recruit executives, advise on strategy, and introduce customers or future investors. Founders, in return, share information they wouldn't give an ordinary shareholder.
That creates an obvious worry: if the same firm backs a competitor, could information from one board find its way - intentionally or not - into decisions about the other investment? Even without deliberate sharing, an investor may carry context about a market, roadmap, hiring plan, or commercial strategy from one company into another.
The traditional norm against backing direct competitors helps reduce that risk. It's never been a perfect safeguard, and it doesn't eliminate every conflict. Still, it gave founders a straightforward expectation: if a firm is deeply involved with your company, it won't also fund a competitor going after the same customers with the same core product.
It gets harder to apply when the companies aren't direct rivals on day one. Startups pivot. Products expand. A company that begins with one customer segment may later move upmarket; a software tool may add an AI agent; a developer product can grow into a broader platform. An investor can make two investments that look distinct at the time, then discover - months or a year later - that the companies have started competing.
A rule built for clearer market boundaries
The norm is easiest when two companies have the same buyer, sell similar products, and compete for the same contracts. It's less clear when they share a technology layer but serve different users - or when one company expands into the other's market.
And this matters because exclusivity isn't just a moral preference. It has a cost. If firms refuse to invest in any company that could someday overlap with an existing portfolio company, they may miss deals across big categories like software, cloud infrastructure, and AI. On the other hand, treating every overlap as acceptable can make a firm's promises to individual founders feel meaningless.
So the goal isn't to pretend overlap can always be eliminated. In a fast market, it often can't. The question is whether the firm spots conflicts early, sets real boundaries, and gives affected founders a credible way to understand how information will be protected.
The Factory-Cognition dispute put the risk in public
This tension came into sharp focus in the dispute involving Factory and Cognition, two startups building AI software-development tools. Factory said it removed board observer and adviser Chris Degnan over alleged unethical conduct involving Cognition. Factory's CEO claimed Degnan discussed a job at Cognition while he had access to board-level discussions. Degnan said he had already resigned and denied sharing confidential information. He later announced he was joining Cognition as chief revenue officer.
Investor Vinod Khosla publicly backed Degnan and criticized Factory's CEO. Khosla Ventures backs both companies. The episode turned what is usually a private question - how investor conflicts are handled - into a public fight about access, disclosure, and trust. The allegations and denials are part of what was reported; they shouldn't be treated as settled facts about what confidential information was or wasn't shared.
Bigger picture: when a firm backs competing companies, people can disagree about whether a conflict exists, what counts as sensitive information, and whether someone's departure is enough to resolve the concern. A policy that sounds clean in a pitch meeting can become much harder to apply once the companies' interests collide.
What Benchmark said - and what it did not say
Benchmark's comments carry weight partly because the firm is known for close, long-term relationships with founders, especially early. At TechCrunch Disrupt, its partners didn't frame competing investments as desirable or harmless. They described conflicts as an increasingly difficult reality as companies evolve.
Eric Vishria said companies change quickly and that conflicts will show up in the current environment. He also said Benchmark stays committed to founders and keeps what it learns confidential. He raised a practical question about how much an investor can pass along in real terms, noting that investors aren't always product or technology experts. At the same time, he said exclusivity is still important at the earliest stage, even as he acknowledged the landscape is changing.
Chetan Puttagunta tied the shift to the falling cost of building software. When it's easier to build, ambitious founders pursue more options. That can increase the odds that portfolio companies drift into one another's territory. He drew a line between backing a direct competitor from the start - something he framed as straightforward - and overlap that appears after a company expands.
Peter Fenton described conflicts as one of the firm's toughest problems. He also put venture investors on a spectrum: at one end, a co-founder wouldn't build a rival; at the other, a public-market investor can hold shares in competing businesses while acting mainly as a capital allocator. Benchmark, he said, sits closer to the co-founder end. He emphasized transparency and suggested founders shouldn't feel blindsided if a conflict later emerges.
The important distinction: commitment versus exclusivity
These comments separate two promises that often get treated like the same thing.
- Confidentiality means a firm doesn't disclose one company's private information to another.
- Exclusivity means the firm agrees not to invest in certain competing businesses.
- Commitment means the firm keeps acting in the company's interest within its role as an investor or board participant.
A firm can say it will keep information confidential without guaranteeing exclusivity. That might be defensible - but it's not the same expectation a founder may assume from a close, high-trust relationship. Founders should ask what kind of commitment they're actually getting, not just rely on general reassurance that the investor has their back.
Benchmark didn't argue the old norm is gone, and it didn't describe every overlap as fine. Instead, the comments point to a more conditional standard: exclusivity may be strongest at the beginning, while later conflicts require disclosure and judgment. That leaves room for ambiguity - and it makes specific expectations more valuable than broad statements about loyalty.
For more detail on the Disrupt discussion and the surrounding events, see TechCrunch's report.
Why AI makes portfolio overlap harder to avoid
AI isn't the only reason companies move into each other's markets, but it can speed up the path from an adjacent feature to a competing product. If teams can build and test software faster, they can explore more directions with less upfront friction. A company that once focused on a narrow workflow can add automation, agents, or a wider platform layer. Then the resulting product may start reaching buyers another startup already serves.
Puttagunta's point about software getting cheaper matters because it turns the competitive landscape from a fixed map into something that shifts every quarter. Investors can't just evaluate overlap by asking what each startup sells at the time of the initial investment. They also have to think about where each company might expand - and how much uncertainty they're willing to live with about those future paths.
None of this means every AI startup will become a competitor to every other one. "AI" isn't a useful substitute for market definition. Two companies can use similar models or techniques while serving different customers, solving different problems, and competing through different channels. On the flip side, products with very different technical foundations can still be direct rivals if they target the same buyer and compete for the same budget.
Map the conflict by customer, product, and information
A useful assessment looks at three things instead of relying on broad labels:
- Customer overlap: Are the companies going after the same decision-makers or competing for the same budget?
- Product overlap: Do they solve the same job, or is one moving toward the other's core use case?
- Information sensitivity: Does the investor have access to plans, metrics, or commercial details that could materially help the competing company?
These answers can change over time. Sharing a customer segment alone doesn't automatically make two companies direct competitors. A product expansion alone doesn't prove confidential information was misused. But together, these signals can tell founders and investors when a previously manageable relationship needs a new conversation.
Faster building doesn't remove the need for market discipline
There's a tempting conclusion that cheaper software means every ambitious direction becomes viable. That doesn't follow. Prototypes might be easier to build, but distribution, reliability, customer trust, compliance, and sales still take real work. A startup can expand into a neighboring category without ever earning a meaningful position there commercially.
That distinction matters for venture conflicts. If investors treat every product extension as a future competitor, they may define exclusivity so broadly that it blocks normal investing. If they dismiss overlap because a new release is "just a feature," they might miss a real threat to an existing company's customers or strategy.
The practical standard should be based on what the companies actually do - who they sell to and what decisions the investor can influence - not on sweeping claims that AI makes markets all identical or endlessly separate.
How founders and investors can handle conflicts
Founders can't control every move a venture firm might make across a portfolio. But they can clarify the boundaries before sensitive information is shared or board access begins. Investors can do the same by flagging relevant portfolio exposure early and being clear about what protections they can realistically provide.
Questions founders should ask before taking an investment
The goal isn't to demand impossible promises. It's to understand the investor's process and decide whether the trade-off works for your company. Ask direct questions like:
- Does the firm already back a company that sells to the same customers or solves a similar problem?
- How does it define a direct competitor: by product, customer, budget, or strategic direction?
- What happens if a portfolio company enters our market after the investment closes?
- Who at the firm will have access to our board materials and confidential information?
- How will the firm disclose a potential overlap, and when?
- What recourse do we have if the conflict becomes material?
Then watch the answers - not just the phrasing. A credible response names the relevant portfolio companies, distinguishes current overlap from possible future overlap, and lays out a process. A vague promise that "we'll handle it" might be sincere, but it doesn't tell you what actually happens when interests diverge.
Founders should also make sure relevant terms are documented when appropriate. Legal agreements and board procedures don't replace trust, but they can clarify access, confidentiality, and the investor's role. Get qualified legal advice on the specific documents - an informal chat shouldn't substitute for a negotiated agreement.
A workable investor process
For venture firms, having a repeatable process helps more than reinventing the response every time a conflict comes up. That process can include:
- Screen before investing: Compare the prospective company's product, buyer, and likely expansion path against existing portfolio companies.
- Disclose meaningful overlap: Share relevant investments before confidential diligence goes too far.
- Define information boundaries: Restrict access to sensitive materials when there's a material conflict, while still letting the company get useful investor support.
- Reassess as markets change: Treat a new product launch or strategic pivot as a reason to revisit the original assessment.
- Communicate before the surprise: Explain what changed, what the firm will do, and what information controls apply.
No process eliminates every disagreement. A firm may decide it can manage a conflict; a founder may decide the risk isn't worth it. The key is to surface that difference before the relationship depends on assumptions neither side has spelled out.
The trade-off is real on both sides
A blanket ban on overlapping investments protects founders from one kind of risk, but it can limit a firm's ability to invest as markets evolve. A permissive approach gives investors more flexibility, but it can weaken the trust that makes early-stage board access possible. Neither option is cost-free.
The right answer depends on the investor's role and what the company needs. A founder expecting an investor to be a close operating partner may reasonably care more about exclusivity and strict information barriers. A company taking capital from a larger, more diversified fund may accept a different relationship - as long as expectations are explicit. The mistake is assuming all investors offer the same level of alignment just because they write venture checks.
Once can be managed through judgment and straightforward communication. Doing it across dozens of investments without a consistent process is where things get messy. As portfolio companies move into adjacent markets, informal norms need operational support: clear disclosures, access controls, and a way to revisit decisions when the situation changes.
Conclusion
AI is making it easier for startups to cross product boundaries. The deeper issue, though, isn't the technology. It's the mismatch between a fast-changing portfolio and a relationship model built on trust, access, and long-term commitment.
Benchmark's comments are a useful signal: even firms that prioritize close founder relationships can't assume portfolio conflicts will stay rare. That doesn't mean every overlapping investment is improper. It does mean founders should separate confidentiality from exclusivity, and investors should explain their limits before a conflict becomes personal.
If you're reviewing a term sheet, make portfolio overlap part of your diligence - not an awkward topic to raise after the board seat is filled. Ask what the investor will do when a company changes direction. The answer will matter far more than a general promise of support.